PAS
KNSA icon

Point72 Asia (Singapore)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Point72 Asia (Singapore)’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$431K Sell
11,101
-14,803
-57% -$481K 0.07% 188
2025
Q2 		$717K Buy
+25,904
New +$659K 0.13% 157

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asia (Singapore)'s KNSA Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Kiniksa Pharmaceuticals (KNSA) stake by 57% in Q3 2025, selling an estimated $481K and leaving 11,101 shares worth $431K. The position accounts for 0.07% of the portfolio, ranked #188.

Point72 Asia (Singapore) first reported a position in KNSA in Q2 2025 and has held it in 2 quarters since. The position peaked at $717K in Q2 2025. 204 funds tracked by Wall St. Rank hold KNSA as of Q3 2025.

  • Point72 Asia (Singapore) held 11,101 shares of Kiniksa Pharmaceuticals worth $431K as of Q3 2025.
  • Point72 Asia (Singapore) sold 14,803 Kiniksa Pharmaceuticals shares in Q3 2025, an estimated $481K.
  • Kiniksa Pharmaceuticals made up 0.07% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #188 holding.
  • Point72 Asia (Singapore) first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Kiniksa Pharmaceuticals position peaked at $717K in Q2 2025.
  • 204 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.